Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. SPY
6. NVDA
7. MSFT
8. LEVI
9. SKYD
10. APLD

Go back to Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance

Bullish Options Activity in Gilead Sciences (GILD) Post Earnings Announcement -Susquehanna

May 3, 2017 2:46 PM EDT

Susquehanna options strategists Alison Edwards notes bullish options activity in Gilead Sciences (NASDAQ: GILD), following the company's earnings announcement, as an opening investor bought ~10,000 Dec 70 Calls for $3.30 creating ~400,000 shares to buy.

... More

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1Q

May 3, 2017 9:17 AM EDT

BMO Capital raised its price target on Gilead Sciences (NASDAQ: GILD) to $76.00 (from $75.00) while maintaining a Market Perform rating. GILD reported 1Q revenues of $6.5bn, below the Street's estimates of $6.62bn, as continued strength from HIV could not off-set further deterioration in HCV.

GILD... More